[The combination of cyclophosphamide, velcade and dexamethasone induces high response rates with comparable toxicity to velcade alone and velcade plus dexamethasone]
>>Haematologica. 2007 Aug;92(8):1149-50.
The combination of cyclophosphamide, velcade and dexamethasone induces high response rates with comparable toxicity to velcade alone and velcade plus dexamethasone.
Davies FE, Wu P, Jenner M, Srikanth M, Saso R, Morgan GJ.
Haemato-oncology Unit, Royal Marsden Hospital, Downs Road, Sutton, Surrey; GB. faith.davies@icr.ac.uk.
The combination of bortezomib (velcade), pulsed dexamethasone and weekly cyclophosphamide (CVD) in relapsed/refractory myeloma patients induces high overall (75%) and complete (31%) response rates compared to velcade/dexamethasone (overall 47%, CR 5%) and velcade alone (overall 27%, CR 0%). The toxicity profiles including thrombocytopenia, neutropenia, and neuropathy were comparable between the groups.<<
Cheers, Tuck |
